Clinical Trial Update: PCV13 + Hepatitis A Vaccine for Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial completed, assessing immune responses to Prevnar 13 and a Hepatitis A vaccine in adults. The study measured immune response outcomes to both vac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Pneumococcal Disease

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)
• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Measurement of Immune Response to Prevenar13, Measurement of Immune Response to Hepatitis A | Phase 4 | Status: COMPLETED